|
|
Yes |
|
|
(n = 73) |
No |
|
|
|
(n = 163) |
|
|
|
|
Treatment setting |
In patient |
43 (58.9%) |
82 (50.3%) |
0.221 |
|
Outpatient |
30 (41.1%) |
81 (49.7%) |
|
Gender |
Male |
44 (60.3%) |
95 (58.3%) |
0.774 |
|
Female |
29 (39.7%) |
68 (41.7%) |
|
Diagnosis |
Leukemia/ lymphoma |
39 (53.4%) |
92 (56.4%) |
0.885 |
|
Solid |
27 (37.0%) |
40 (24.5%) |
*0.034 |
|
CNS |
7 (9.6%) |
31 (19.0%) |
0.086 |
Acute Nausea |
Yes |
20 (28.2%) |
52 (35.4%) |
0.289 |
|
No |
51 (71.8%) |
95 (64.6%) |
|
Acute Nausea Degree categorize |
No Nausea |
51 (71.8%) |
95
(64.6%) |
*0.046 |
|
Mild nausea |
8 (11.3%) |
12 (8.2%) |
0.317 |
|
Moderate nausea |
6 (8.5%) |
26 (17.7%) |
0.131 |
|
Severe nausea |
6 (8.5%) |
14 (9.5%) |
0.183 |
Acute Vomiting |
Yes |
9 (12.7%) |
35 (24.0%) |
0.052 |
|
No |
62 (87.3%) |
111 (76.0%) |
|
Acute Feeding Tolerance |
Yes |
44 (62.0%) |
77 (52.4%) |
0.182 |
|
No |
27 (38.0%) |
70 (47.6%) |
|
Acute Tolerate Feeding Degree (%) Categorize |
Severe |
12
(16.9%) |
42 (28.6%) |
0.115 |
|
Moderate |
10 (14.1%) |
14 (9.5%) |
0.230 |
|
Mild |
13 (18.3%) |
27 (18.4%) |
0.814 |
|
Normal |
36 (50.7%) |
64 (43.5%) |
0.149 |
Delayed Nausea |
Yes |
19 (27.9%) |
51 (36.7%) |
0.211 |
|
No |
49 (72.1%) |
88 (63.3%) |
|
Delayed Nausea Degree Categorize (%) |
No Nausea |
49 (67.1%) |
88 (54.0%) |
0.059 |
|
Mild nausea |
9 (12.3%) |
18 (11.0%) |
0.774 |
|
Moderate nausea |
6 (8.2%) |
20 (12.3%) |
0.358 |
|
Severe nausea |
9 (12.3%) |
37 (22.7%) |
0.063 |
Delayed Vomiting |
Yes |
8 (11.8%) |
31 (22.3%) |
0.123 |
|
No |
60 (88.2%) |
108 (77.7%) |
|
Delayed Food Tolerance |
Yes |
43 (63.2%) |
79 (56.4%) |
0.138 |
|
No |
25 (36.8%) |
61 (43.6%) |
|
Delayed Food Tolerance Degree (%) Categorize |
Severe |
7
(10.3%) |
30 (21.4%) |
0.085 |
|
Moderate |
8 (11.8%) |
16 (11.4%) |
0.788 |
|
Mild |
18 (26.5%) |
27 (19.3%) |
0.144 |
|
Normal |
35 (51.5%) |
67 (47.9%) |
0.327 |